SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 571 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,195,835 | +3.7% | 175,328 | -5.9% | 0.12% | +14.9% |
| Q2 2023 | $35,857,415 | +60.4% | 186,311 | +68.8% | 0.10% | +50.7% |
| Q1 2023 | $22,351,068 | +61.4% | 110,392 | +2.4% | 0.07% | +48.9% |
| Q4 2022 | $13,849,137 | -15.2% | 107,767 | -9.7% | 0.04% | -13.5% |
| Q3 2022 | $16,328,000 | -30.2% | 119,330 | -9.7% | 0.05% | -14.8% |
| Q2 2022 | $23,394,000 | +9.9% | 132,217 | -10.5% | 0.06% | +38.6% |
| Q1 2022 | $21,277,000 | -12.1% | 147,703 | -5.6% | 0.04% | -6.4% |
| Q4 2021 | $24,201,000 | -16.8% | 156,540 | -8.6% | 0.05% | -21.7% |
| Q3 2021 | $29,089,000 | +12.8% | 171,316 | +4.9% | 0.06% | +13.2% |
| Q2 2021 | $25,780,000 | +14.5% | 163,286 | +0.7% | 0.05% | +10.4% |
| Q1 2021 | $22,516,000 | -15.8% | 162,150 | +6.2% | 0.05% | -22.6% |
| Q4 2020 | $26,731,000 | – | 152,624 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |